Beneficios de Phyllanthus niruri en el control de la diabetes

2014 ◽  
Author(s):  
Mairin Josefina Lemus Barrios ◽  
◽  
Yusmar Ramos ◽  
Ahieska Liscano ◽  
Haydelba D'Armas ◽  
...  
Keyword(s):  
Phyllanthus Niruri

1696: May Phyllanthus Niruri ( Uriston®) Affect the Efficacy of ESWL on Renal Stones? A Prospective, Randomised Short Term Study

2005 ◽  
Vol 173 (4S) ◽  
pp. 460-460
Author(s):  
Antonio Celia ◽  
Salvatore Micali ◽  
Sighinolfi Maria Chiara ◽  
Grande Marco ◽  
Di Pietro Corradino ◽  
...  
Keyword(s):  
Renal Stones ◽  
Short Term ◽  
Phyllanthus Niruri ◽  
Term Study ◽  
Short Term Study

Phytotherapy and Herbal Medicines for Kidney Stones

2020 ◽  
Vol 22 (1) ◽  
pp. 22-30
Author(s):  
Esteban Emiliani ◽  
Adrian Jara ◽  
Andres Koey Kanashiro
Keyword(s):  
Uric Acid ◽  
Calcium Oxalate ◽  
Kidney Stones ◽  
Animal Studies ◽  
Randomized Clinical Trials ◽  
Herbal Medicines ◽  
Phyllanthus Niruri ◽  
Treatment And Prevention ◽  
Number Of Patients ◽  
Uric Acid Stones

Background: Kidney stones are one of the oldest known and common diseases in the urinary tract with a prevalence that varies from 1% to 20%. Many phytotherapic and herbal medicines for kidney stones have been described for their treatment and prevention. Objective: The objective of this study is to perform a comprehensive review of several phytotherapic and herbal medicines published including clinical and animal studies. Results: Phytotherapy may influence the risk of recurrence in calcium oxalate and uric acid stones. The most solid evidence suggest that Phyllanthus niruri is one of the most studied components that appear to interfere with the calcium oxalate crystallization, reduced hyperoxaluria and hiperuricosuria and increased shock wave lithotripsy efficacy due to reduced crystallization without significant adverse effects, also Theobromine have shown to reduce the crystallization of uric acid in patients and appears to be a promising supplement to treat such stones. Conclusion: Many phytoterapic and herbal agents have been studies to treat and present urolithiasis, most of them only with studies of small number of patients or in animal models. Further randomized clinical trials are needed to evaluate the effect of these agents in kidney stones.

In-vitro Antimicrobial Activities of Pongamia glabra and Phyllanthus niruri

2016 ◽  
Vol 2 (2) ◽  
pp. 236 ◽  
Author(s):  
N. Mahalakshmi ◽  
S. Dhanasekaran ◽  
C. Ravi ◽  
S. Lingathurai
Keyword(s):  
Antimicrobial Activities ◽  
Phyllanthus Niruri ◽  
Pongamia Glabra

Противовирусная активность Phyllanthus niruri (Phyllanthaceae)

2019 ◽  
Vol 55 (4) ◽  
pp. 439-448
Author(s):  
Ю. А. Морозова ◽  
Д. С. Дергачев ◽  
М. А. Суботялов
Keyword(s):  
Phyllanthus Niruri

Phenolic constituents in tissue cultures of Phyllanthus niruri

1992 ◽  
Vol 31 (6) ◽  
pp. 2015-2018 ◽  
Author(s):  
Kanji Ishimaru ◽  
Kayo Yoshimatsu ◽  
Takashi Yamakawa ◽  
Hiroshi Kamada ◽  
Koichiro Shimomura
Keyword(s):  
Tissue Cultures ◽  
Phyllanthus Niruri ◽  
Phenolic Constituents

scholarly journals Identification of sitosteryl glucoside palmitate in a chloroform-derived fraction of Phyllanthus niruri with antiplasmodial and peripheral antinociceptive properties

2014 ◽  
Vol 4 (9) ◽  
pp. 707-713
Author(s):  
Ezenyi Ifeoma Chinwude ◽  
Kulkarni Roshan ◽  
Joshi Swati ◽  
Salawu Oluwakanyinsola Adeola ◽  
Emeje Martins
Keyword(s):  
Phyllanthus Niruri

scholarly journals Evaluation of (anti)genotoxic activities of Phyllanthus niruri L. in rat bone marrow using the micronucleus test

2013 ◽  
Vol 49 (1) ◽  
pp. 135-148 ◽  
Author(s):  
Fernando Márlisson de Queiroz ◽  
Kayo Wanderson de Oliveira Matias ◽  
Mylena Mylana Freire da Cunha ◽  
Aline Schwarz
Keyword(s):  
Bone Marrow ◽  
Body Weight ◽  
Weight Gain ◽  
Micronucleus Test ◽  
Body Weight Gain ◽  
Tap Water ◽  
Control Group ◽  
Cytotoxic Activities ◽  
Phyllanthus Niruri ◽  
Polychromatic Erythrocytes

Phyllanthus niruri L. (Euphorbiaceae), known as "quebra-pedra" (Portuguese for "stonebreaker"), is an herb used for kidney disorders. In light of its frequent use by the population, the present study aimed to investigate the genotoxic, antigenotoxic and cytotoxic activities of a standardized P. niruri extract in bone marrow rats. Three groups of 12 animals were treated daily by gavage over a period of 30 days, with 50, 150 or 250 mg/kg of P. niruri extract aqueous solution. The control group (n = 12) received tap water. At the end of treatment (day 31), groups were divided into two minor subgroups (n=6/group) and received cyclophosphamide (50 mg/kg, i.p.) or saline 0.9% (i.p.). After 24 hours, we evaluated the frequency of micronucleated polychromatic erythrocytes for each animal (MNPCE) at 1000 PCE. Cytotoxicity was evaluated with the PCE/NCE ratio (NEC = normochromatic erythrocytes). General toxicity was assessed during treatment using the parameters of body weight gain, ration and water consumption. The dry extract did not provoke changes in body weight, weight gain, ration and water intake or changes in the frequency of MNPCE or cytotoxicity in bone marrow. We propose that the P. niruri extract used here showed no genotoxic, antigenotoxic and cytotoxic activities under the experimental conditions.

Sign in / Sign up

Export Citation Format

Share Document